Dr Orest Lastow is the founder and CTO of Iconovo AB. He was the first CEO of Iconovo and is also the inventor of Iconovo’s five inhalation device platforms. He is the founder and previous CEO of Medicon Valley Inhalation Consortium, MVIC AB and was with AstraZeneca for over 15 years and is the principal inventor of AstraZeneca’s new dry powder inhalation platform. Orest is the inventor behind over 40 patents and patent applications.
Orest received a M.Sc. in Engineering Physics and a Licentiate of Engineering degree in Aerosol Science from Lund University. He has also a Ph.D. in electrohydrodynamic atomization from Brunel University. His expertise is device development, electrostatics, Computational Fluid Dynamics (CFD), aerosol science and inhalation technology. He is the author behind a textbook on EHD atomization, several journal publications and book contributions. He is frequently invited to speak at conferences and teaches aerosol drug delivery at Lund University and Copenhagen University. Orest is a co-author of the Aerosol drug delivery device design verification standard (ISO 20072).